BridgeBio · 5 hours ago
Director, Commercial Analytics & Insights
BridgeBio is a pioneering company in biotech focused on developing life-changing medicines for patients with unmet needs. They are seeking a strategically minded and analytically gifted Director of Commercial Analytics & Insights to guide launch planning and strategic decision-making for a rare disease product.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Develop and execute an integrated analytics strategy that supports pre-launch efforts and evolves into post-launch optimization
Analyze market trends, HCP and patient engagement data, and early launch metrics to guide brand and access strategies
Monitor and interpret key performance indicators such as new patient starts, conversion, adherence, and call activity
Influence sales analytics framework to support field force performance, territory optimization, and incentive compensation strategies
Guide construction of patient-based models that incorporate epidemiology, diagnosis and treatment journey dynamics, access variability, and rare disease market constraints, and track launch performance versus forecast
Partner with Finance, Supply Chain, and other departments on demand planning, inventory management, and long-range strategic planning
Identify business questions to be addressed by primary market research, and guide the design of research with physicians, patients, and caregivers in the rare disease space
Uncover insights into patient journeys, treatment paradigms, stakeholder unmet needs, and messaging receptivity to inform brand positioning and launch tactics
Synthesize qualitative and quantitative findings into actionable strategic guidance for cross-functional teams
Establish a fit-for-purpose competitive intelligence capability
Monitor competitor activities including clinical development, regulatory events, commercial strategy, and advocacy engagement
Qualification
Required
Bachelor's degree required
7+ years of experience in commercial analytics and insights, including responsibilities in forecasting, market research, data analytics, and CI within the biotech/pharma industry
2+ years of leadership experience
Proven experience supporting or leading a product launch, ideally in a therapeutic area with limited precedent or data availability
Experience in rare disease data sources, epidemiology-based forecasting, and stakeholder mapping
Expertise in U.S. healthcare data sources (e.g., specialty pharmacy data, claims data, IQVIA, Symphony, Komodo, CRM systems like Veeva)
Technical proficiency in Excel, PowerPoint, and analytics/visualization platforms (e.g., Power BI, Tableau)
Highly collaborative and proactive, with excellent storytelling, communication, and executive presentation skills
Preferred
advanced degree (MBA, MS, PharmD, PhD) strongly preferred
rare disease or specialty product experience highly preferred
Benefits
401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
Career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
Celebration of strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
Funding
Current Stage
Public CompanyTotal Funding
$4.9BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Debt Financing· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
Recent News
2026-01-05
2025-12-24
Company data provided by crunchbase